Bessemer Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5K Sell
151
-141
-48% -$4.67K ﹤0.01% 2044
2025
Q1
$10K Sell
292
-111
-28% -$3.8K ﹤0.01% 1788
2024
Q4
$14K Buy
403
+141
+54% +$4.9K ﹤0.01% 1637
2024
Q3
$8K Sell
262
-60
-19% -$1.83K ﹤0.01% 1765
2024
Q2
$8K Buy
322
+231
+254% +$5.74K ﹤0.01% 1594
2024
Q1
$3K Sell
91
-129
-59% -$4.25K ﹤0.01% 1896
2023
Q4
$7K Buy
220
+50
+29% +$1.59K ﹤0.01% 1686
2023
Q3
$5K Buy
170
+17
+11% +$500 ﹤0.01% 1758
2023
Q2
$4K Buy
153
+45
+42% +$1.18K ﹤0.01% 1894
2023
Q1
$4K Sell
108
-26
-19% -$963 ﹤0.01% 1707
2022
Q4
$5K Hold
134
﹤0.01% 1595
2022
Q3
$5K Hold
134
﹤0.01% 1715
2022
Q2
$4K Hold
134
﹤0.01% 1628
2022
Q1
$4K Sell
134
-25
-16% -$746 ﹤0.01% 1621
2021
Q4
$5K Buy
+159
New +$5K ﹤0.01% 1595
2021
Q1
Sell
-289
Closed -$7K 1657
2020
Q4
$7K Buy
+289
New +$7K ﹤0.01% 1344
2019
Q4
Sell
-275
Closed -$8K 1761
2019
Q3
$8K Buy
+275
New +$8K ﹤0.01% 1506
2019
Q2
Hold
0
1843
2019
Q1
Sell
-5,500
Closed -$183K 1962
2018
Q4
$183K Hold
5,500
﹤0.01% 1002
2018
Q3
$277K Sell
5,500
-900
-14% -$45.3K ﹤0.01% 920
2018
Q2
$383K Buy
+6,400
New +$383K ﹤0.01% 843
2016
Q2
Sell
-38,723
Closed -$591K 1447
2016
Q1
$591K Sell
38,723
-176,424
-82% -$2.69M ﹤0.01% 532
2015
Q4
$2.89M Buy
215,147
+38,512
+22% +$518K 0.02% 359
2015
Q3
$2.48M Buy
176,635
+161,515
+1,068% +$2.27M 0.01% 370
2015
Q2
$257K Buy
+15,120
New +$257K ﹤0.01% 722